Published June 14, 2021 | Version v3
Other Open

Effects of Tirzepatide, a Dual GIP and GLP-1 Receptor Agonist, on Lipid and Metabolite Profiles in Subjects with Type 2 Diabetes Supplementary Information

Description

This is the supplementary information for the manuscript "Effects of Tirzepatide, a Dual GIP and GLP-1 Receptor Agonist, on Lipid and Metabolite Profiles in Subjects with Type 2 Diabetes"

Files